Ultra V, Ultracol Received Great Response from Pakistan PAADS

Sharing the latest beauty medical technology and treatment 

trends for local beauty and plastic surgery professionals

CEO Kwon Han-Jin, “Providing innovative and safe products to 

consumers around the world”

Biomedical Beauty Group Ultra V (CEO Kwon Han-Jin) announced that it held a lecture about Ultracol & Ultra V thread lifting for local doctors at the famous dermatology conference ‘PAADS International Anti-aging Congress 2024’ held in Karachi, Pakistan.

Ultra V held a lecture on Ultracol & Ultra V thread lifting for local doctors at the dermatology conference ‘PAADS International Anti-aging Congress 2024’ held in Karachi, Pakistan.

At the lecture held that day, the latest beauty medical technology and treatment trends were shared with local medical staff and officials in the field of beauty and plastic surgery, and the latest knowledge and clinical cases were introduced to numerous local medical staff.

K-beauty evangelist Kwon Han-Jin has been passionately leading the way in beauty technology evangelism to the point that he has not hesitated to visit Pakistan for several years. He resumed visiting Pakistan last year to resume exchanges that had been cut off since COVID-19 and received a great response with the evaluation that he was able to learn innovative know-how from the medical staff and officials who attended that day.

The estimated size of the Pakistani medical device market is approximately 500-600 million dollars as of 2023 and it is growing rapidly every year. It is steadily growing by continuously expanding the market share to overcome the medical infrastructure and the position related to beauty medicine is expanding further due to the Korean Wave.

The product that received the most attention and interest that day was ‘Ultracol’. ‘Ultracol’ is made by Ultra V’s own technology, a microsphere made with PDO (Polydioxanone) ingredients registered with the FDA, which promotes the production of self-collagen through foreign body reaction. Afterwards, it is broken down and has the effect of improving wrinkles through collagen and significantly reduces the risk of side effects.

This product has been recognized for its technology and has obtained approval from the Ministry of Food and Drug Safety (KFDA) and European CE certification, and has won the IR52 Jang Young-sil Award and the Republic of Korea Patent Award for its unique patented technology. In addition, as the collagen concentration in the injection site increases, it not only improves skin elasticity and whitening effects, but also has an additional lifting effect, making it a highly satisfactory product for users.

CEO Kwon Han-Jin emphasized, “Korea is a major country leading the latest beauty medical technology trends around the world, so we received a lot of interest from local medical professionals who attended this seminar,” and “Ultra V will continue to focus its capabilities on providing more innovative and safe products to consumers not only in Korea but also around the world through active communication and exchange.” 

Meanwhile, Ultra V is a global biomedical beauty group that exports and sells to over 50 countries around the world and is at the forefront of K-beauty exports. Starting with its main products, ‘Ultracol’ and ‘Ultra V Lifting,’ it is striving to become a leading company that promotes the competitiveness of K-beauty to the world.